Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer

NCT03748680 is registered in ClinicalTrials.gov with Karen-Lise Garm Spindler as lead sponsor.

NCT NCT03748680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03748680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer
Lead sponsor
Karen-Lise Garm Spindler
Phase
Phase 2
Overall status
Unknown status
Start date
October 1, 2018
Completion date
October 1, 2025
Enrollment
64 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant chemotherapy, circulating tumor dna, colorectal cancer, progression free survival